[1] BIBIKOVA M,BEUMER K,TRAUTMAN JK,et al.Enhancing gene targeting with designed zinc finger nucleases[J].Science,2003,300(5620):764-764.
|
[2] BIBIKOVA M,GOLIC M,GOLIC KG,et al.Targeted chromosomal cleavage and mutagenesis in Drosophila using zinc-finger nucleases[J].Genetics,2002,161(3):1169-1175.
|
[3]IRION U,KRAUSS J,NSSLEIN-VOLHARD C.Precise and efficient genome editing in zebrafish using the CRISPR/Cas9 system[J].Development,2014,141(24):4827-4830.
|
[4]RYAN OW,CATE JH.Multiplex engineering of industrial yeast genomes using CRISPRm[J].Methods Enzymol,2014,546:473-489.
|
[5]QIN W,DION SL,KUTNY PM,et al.Efficient CRISPR/Cas9-mediated genome editing in mice by zygote electroporation of nuclease[J].Genetics,2015,200(2):423-430.
|
[6]JIANG W,ZHOU H,BI H,et al.Demonstration of CRISPR/Cas9/sgRNA-mediated targeted gene modification in Arabidopsis,tobacco,sorghum and rice[J].Nucleic Acids Res,2013,41(20):e188.
|
[7]GRISSA I,VERGNAUD G,POURCEL C.The CRISPRdb database and tools to display CRISPRs and to generate dictionaries of spacers and repeats[J].BMC Bioinformatics,2007,8:172.
|
[8]GARNEAU JE,DUOUIS ME,VILLION M,et al.The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA[J].Nature,2010,468(7320):67-71.
|
[9]DELTCHEVA E,CHYLINSKI K,SHARMA CM,et al.CRISPR RNA maturation by trans-encoded small RNA and host factor RNaseⅢ[J].Nature,2011,471(7340):602-607.
|
[10] CONG L,RAN FA,COX D,et al.Multiplex genome engineering using CRISPR/Cas systems[J].Science,2013,339(6121):819-823.
|
[11]SUENAGE T,KOHYAMA M,HIRAYASU K,et al.Engineering large viral DNA genomes using the CRISPR-Cas9 system[J].Microbiol Immunol,2014,58(9):513-522.
|
[12]JOHNSON KE,BOTTERO V,FLAHERTY S,et al.IFI16 restricts HSV-1 replication by accumulating on the hsv-1 genome,repressing HSV-1 gene expression,and directly or indirectly modulating histone modifications[J].PLo S Pathog,2014,10(11):e1004503.
|
[13]BI Y,SUN L,GAO D,et al.High-efficiency targeted editing of large viral genomes by RNA-guided nucleases[J].PLo S Pathog,2014,10(5):e1004090.
|
[14]ROBLES-SIKISAKA R,LY M,BOEHM T,et al.Association between living environment and human oral viral ecology[J].ISME J,2013,7(9):1710-1724.
|
[15]GU WG,CHEN XQ.Targeting CCR5 for anti-HIV research[J].Eur J Clin Microbiol Infect Dis,2014,33(11):1881-1887.
|
[16]HU W,KAMINSKI R,YANG F,et al.RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection[J].Proce Nati Acad Sci U S A,2014,111(31):11461-11466.
|
[17]SCHIFFER JT,SWAN DA,STONE D,et al.Predictors of hepatitis B cure using gene therapy to deliver DNA cleavage enzymes:a mathematical modeling approach[J].PLo S Comput Biol,2013,9(7):e1003131.
|
[18]LIN SR,YANG HC,KUO YT,et al.The CRISPR/Cas9 system facilitates clearance of the intrahepatic HBV templates in vivo[J].Mol Ther Nucleic Acids,2014,3:e186.
|
[19]DONG C,QU L,WANG H,et al.Targeting hepatitis B virus ccc DNA by CRISPR/Cas9 nuclease efficiently inhibits viral replication[J].Antiviral Res,2015,118:110-117.
|
[20]SEEGER C,SOHN JA.Targeting hepatitis B virus with CRISPR/Cas9[J].Mol Ther Nucleic Acids,2014,3(12):e216.
|
[21]ZHEN S,HUA L,LIU YH,et al.Harnessing the clustered regularly interspaced short palindromic repeat(CRISPR)/CRISPR-associated Cas9 system to disrupt the hepatitis B virus[J].Gene Ther,2015,22(5):402-412.
|
[22]KENNEDY EM,BASSIT LC,MUELLER H,et al.Suppression of hepatitis B virus DNA accumulation in chronically infected cells using a bacterial CRISPR/Cas RNA-guided DNA endonuclease[J].Virology,2015,476:196-205.
|
[23]VOCKERODT M,YAP LF,SHANNON-LOWE C,et al.The Epstein-Barr virus and the pathogenesis of lymphoma[J].J Pathol,2015,235(2):312-322.
|
[24]WANG J,QUAKE SR.RNA-guided endonuclease provides a therapeutic strategy to cure latent herpesviridae infection[J].Proc Natl Acad Sci U S A,2014,111(36):13157-13162.
|
[25]CHO SW,KIM S,KIM Y,et al.Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases[J].Genome Res,2014,24(1):132-141.
|
[26]GHEZRAOUI H,PIGANEAU M,RENOUF B,et al.Chromosomal translocations in human cells are generated by canonical nonhomologous end-joining[J].Mol Cell,2014,55(6):829-842.
|
[27]TSAI SQ,WYVEKENS N,KHAYTER C,et al.Dimeric CRISPR RNA-guided Fokl nucleases for highly specific genome editing[J].Nat Biotechnol,2014,32(6):569-576.
|
[28]RAMAKRISHNA S,KWAKU DAD AB,BELOOR J,et al.Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein and guide RNA[J].Genome Res,2014,24(6):1020-1027.
|
[29]KOTTERMAN MA,SCHAFFER DV.Engineering adeno-associated viruses for clinical gene therapy[J].Nat Rev Genet,2014,15(7):445-451.
|
[30]KIM S,KIM D,CHO SW,et al.Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins[J].Genome Res,2014,24(6):1012-1019.
|